Merck (MRK) Equity Average (2009 - 2026)
Merck (MRK) reported Equity Average of $49.3 billion for Q1 2026, up 3.98% year-over-year from $47.4 billion in Q1 2025, and down 5.71% on a QoQ basis from $52.3 billion in Q4 2025.
Merck (MRK) has 18 years of Equity Average data on file, last reported at $49.3 billion in Q1 2026.
- Quarterly Equity Average rose 3.98% year-over-year to $49.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.3 billion (up 3.98% YoY) and the FY2025 annual result came in at $49.5 billion, up 17.89% from the prior year.
- Equity Average retreated to $49.3 billion in Q1 2026 per MRK's latest filing, from $52.3 billion in the prior quarter.
- Across five years, Equity Average topped out at $52.3 billion in Q4 2025 and bottomed at $39.0 billion in Q1 2024.
- The 5-year median for Equity Average is $44.1 billion (2024), against an average of $44.6 billion.
- The widest annual swing landed in 2022, when Equity Average surged 51.04%; it then dropped 16.03% in 2024.
- Tracing MRK's Equity Average over 5 years: stood at $45.3 billion in 2022, then dropped by 12.86% to $39.5 billion in 2023, then rose by 15.2% to $45.5 billion in 2024, then rose by 14.93% to $52.3 billion in 2025, then slipped by 5.71% to $49.3 billion in 2026.
- Per Business Quant, the three latest MRK Equity Average figures stand at $49.3 billion (Q1 2026), $52.3 billion (Q4 2025), and $50.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 28.87 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 81.37 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -4.96 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 49.27 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 8.92 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 23.11 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 88.29 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 19.27 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 19.67 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.27 Bn |
| Dec 31, 2025 | 52.26 Bn |
| Sep 30, 2025 | 50.46 Bn |
| Jun 30, 2025 | 48.73 Bn |
| Mar 31, 2025 | 47.39 Bn |
| Dec 31, 2024 | 45.47 Bn |
| Sep 30, 2024 | 44.10 Bn |
| Jun 30, 2024 | 42.04 Bn |
| Mar 31, 2024 | 39.03 Bn |
| Dec 31, 2023 | 39.47 Bn |
| Sep 30, 2023 | 40.02 Bn |
| Jun 30, 2023 | 42.82 Bn |
| Mar 31, 2023 | 46.48 Bn |
| Dec 31, 2022 | 45.29 Bn |
| Sep 30, 2022 | 43.92 Bn |
| Jun 30, 2022 | 42.14 Bn |
| Mar 31, 2022 | 39.61 Bn |
| Dec 31, 2021 | 37.06 Bn |
| Sep 30, 2021 | 34.63 Bn |
| Jun 30, 2021 | 30.21 Bn |
| Mar 31, 2021 | 26.22 Bn |
| Dec 31, 2020 | 27.34 Bn |
| Sep 30, 2020 | 28.51 Bn |
| Jun 30, 2020 | 27.02 Bn |
| Mar 31, 2020 | 26.15 Bn |
| Dec 31, 2019 | 26.46 Bn |
| Sep 30, 2019 | 27.33 Bn |
| Jun 30, 2019 | 27.70 Bn |
| Mar 31, 2019 | 27.28 Bn |
| Dec 31, 2018 | 29.77 Bn |
| Sep 30, 2018 | 32.71 Bn |
| Jun 30, 2018 | 33.33 Bn |
| Mar 31, 2018 | 34.24 Bn |
| Dec 31, 2017 | 36.53 Bn |
| Sep 30, 2017 | 39.11 Bn |
| Jun 30, 2017 | 19.91 Bn |
| Mar 31, 2017 | 20.21 Bn |
| Dec 31, 2016 | 42.13 Bn |
| Sep 30, 2016 | 22.03 Bn |
| Jun 30, 2016 | 107.50 Mn |
| Mar 31, 2016 | 22.44 Bn |
| Dec 31, 2015 | 45.22 Bn |
| Sep 30, 2015 | 46.16 Bn |
| Jun 30, 2015 | 47.28 Bn |
| Mar 31, 2015 | 48.35 Bn |
| Dec 31, 2014 | 47.08 Bn |
| Sep 30, 2014 | 46.94 Bn |
| Jun 30, 2014 | 50.54 Bn |
| Mar 31, 2014 | 52.45 Bn |
| Dec 31, 2013 | 51.17 Bn |
| Sep 30, 2013 | 50.06 Bn |
| Jun 30, 2013 | 52.86 Bn |
| Mar 31, 2013 | 55.53 Bn |
| Dec 31, 2012 | 56.84 Bn |
| Sep 30, 2012 | 57.94 Bn |
| Jun 30, 2012 | 57.49 Bn |
| Mar 31, 2012 | 57.13 Bn |
| Dec 31, 2011 | 56.04 Bn |
| Sep 30, 2011 | 56.53 Bn |
| Jun 30, 2011 | 57.38 Bn |
| Mar 31, 2011 | 56.82 Bn |
| Dec 31, 2010 | 57.43 Bn |
| Sep 30, 2010 | 57.85 Bn |
| Jun 30, 2010 | 59.00 Bn |
| Mar 31, 2010 | 60.91 Bn |
| Dec 31, 2009 | 43.42 Bn |
| Sep 30, 2009 | 24.04 Bn |